March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Pharmacokinetic Parameters Determined For A Fluoroquinolone In The Eye Of Rabbits And Multiple Dosage Regimens Prediction
Author Affiliations & Notes
  • Juan Carlos Rivera-Castro, Sr.
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • José Rubén Tornero-Montaño
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • Juan de Dios Quintana-Hau
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • Humberto Figueroa-Ponce
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • Abida Carrillo-Guzmán
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • Luis Gerardo Urquidez-Espinoza
    R & D, Laboratorios Sophia SA de CV, Zapopan, Mexico
  • Footnotes
    Commercial Relationships  Juan Carlos Rivera-Castro, Sr., Laboratorios Sophia SA de CV (F); José Rubén Tornero-Montaño, Laboratorios Sophia SA de CV (F); Juan de Dios Quintana-Hau, Laboratorios Sophia SA de CV (F); Humberto Figueroa-Ponce, Laboratorios Sophia SA de CV (F); Abida Carrillo-Guzmán, Laboratorios Sophia SA de CV (F); Luis Gerardo Urquidez-Espinoza, Laboratorios Sophia SA de CV (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Juan Carlos Rivera-Castro, Sr., José Rubén Tornero-Montaño, Juan de Dios Quintana-Hau, Humberto Figueroa-Ponce, Abida Carrillo-Guzmán, Luis Gerardo Urquidez-Espinoza; Pharmacokinetic Parameters Determined For A Fluoroquinolone In The Eye Of Rabbits And Multiple Dosage Regimens Prediction. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Determine pharmacokinetic parameters of the compound in study after a single dose. Use the single dose pharmacokinetic parameters to predict the steady-state of multiple dosage regimens for the determination of an appropriate dosage interval.

 
Methods:
 

There were used 54 male New Zeland white Rabbits with a weight between 2.0 and 3.0 kg, using 9 rabbits per time, the dosage administered was 30 μL of quinolone solution 0.3%, the Rabbits were sacrificed at the corresponding time 15, 30, 60, 90, 120 and 180 minutes, following the extraction of the humor aqueous. The concentration of the quinolone was determined using HPLC coupled to an UV detector. The pharmacokinetics parameters were determined using first order reaction equations and one compartment model. For the multiple dosage prediction was applied the principle of superposition which allows to project the concentration-time curve of a drug after several consecutive doses based on the drug concentration-time curve obtained after a single dose.

 
Results:
 

Pharmacokinetics parameters were obtained: absorption constant ka=1.70008hr-1, elimination constant k=0.3078hr-1, fraction of dose absorbed F=0.002. Using this parameters concentration curves for different dosage intervals were constructed.

 
Conclusions:
 

The MIC90 for most of the quinolones is between 100-2000 ng/mL. An appropriate dosage interval for reaching therapeutic levels is every 4 hours in which the steady-state predicted is between Cmin=362 ng/mL and Cmax=751 ng/mL, this steady-state was reached after the fourth dosage.  

 

 
Keywords: antibiotics/antifungals/antiparasitics • aqueous • anterior chamber 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×